We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Low Folate Levels Can Indicate Malnutrition in Hospital Patients

By LabMedica International staff writers
Posted on 04 Mar 2020
Print article
Image: Serum folate and B vitamins should be tested in certain patients than are being hospitalized (Photo courtesy of Toliopoulos Diagnostics/Roche).
Image: Serum folate and B vitamins should be tested in certain patients than are being hospitalized (Photo courtesy of Toliopoulos Diagnostics/Roche).
Folate deficiency, also known as vitamin B9 deficiency, is a low level of folate and derivatives in the body. Signs of folate deficiency are often subtle. A low number of red blood cells (anemia) are a late finding in folate deficiency and folate deficiency anemia is the term given for this medical condition.

About 10% of patients who come to complex care hospitals may have low levels of folate and other indicators of malnutrition. To ensure those patients are identified and helped, those who present with gastrointestinal problems, chronic kidney disease or sepsis, all associated with malnutrition, need to have their folate levels tested on admission.

Scientists at the Medical College of Georgia (Augusta, GA, USA) reviewed the medical records of 1,019 patients with serum folate less than 7.0 ng/mL, 301 patients with serum folate of 15 ng/mL, and 300 patients with serum folate more than 23 ng/mL.

The investigators reported that serum pre-albumin levels were subnormal in 54.8% of patients with serum folate less than 7.0 ng/mL. Vitamin B12, hemoglobin, and serum albumin levels were significantly lower in the less than 7.0 ng/mL folate group. One or more markers of malnutrition were present in 62.4% of patients with serum folate less than 7.0 ng/mL. The low-folate group had a significantly higher prevalence of gastrointestinal (GI) disorders, sepsis, and abnormal serum creatinine level. There were no significant differences in the two groups regarding diabetes; behavioral/neurological disorders, including drug and alcohol abuse; bariatric surgery; or a diagnosis of malnutrition.

A complicating factor was that as many as 60% of the patients the team reviewed had received a folic acid supplement before they were tested, which meant that low folate levels could be even more prevalent. That finding and other indicators of nutritional deficiency prompted the AU Health System to urge medical staff to do folic acid testing before any supplements or blood products were given, even before patients eat a hospital meal. The health system's Medical Executive Board also approved automatic testing for prealbumin and B12 in those found to have a folate level of less than 7ng/mL.

Gurmukh Singh, MD, PhD, MBA, vice chair of pathology and senior author of the study, said, “We looked at people who had low levels and relatively normal folate levels. The people with low levels had a higher incidence of gastrointestinal disorders like chronic diarrhea as well as sepsis and kidney disease. The other piece was that people who had low levels also had other markers of malnutrition.”

The authors concluded that the prevalence of folate deficiency depends on what is considered a normal serum folate level. Approximately 10% of tertiary-care patients have level less than 7.0 ng/mL and exhibit other markers of malnutrition. It is recommended that patients with GI disorders, chronic kidney disease, and sepsis be routinely tested for serum folate levels, before administration of vitamin supplements. Patients with serum folate levels less than 7.0 ng/mL should be evaluated for malnutrition and Folate supplementation should be administered only after excluding coexisting vitamin B12 deficiency. The study was published on Januarys 30, 2020 in the Laboratory Medicine.

Related Links:
Medical College of Georgia

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Immunoassays and Calibrators
QMS Tacrolimus Immunoassays

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.